Madrid, Spain and Heidelberg, Germany -– SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed an initial distribution agreement for its first proprietary product with German BioCat GmbH. With this agreement, SYGNIS grants BioCat non-exclusive rights to promote, market, sell, and support TruePrime™ Single Cell WGA kit for the DNA […]

WILMINGTON, Mass.–– Kapa Biosystems, Inc. today announced that they have expanded their partnership with Roche NimbleGen to include new, optimized, RNA sample-preparation methods for targeted RNA next-generation sequencing (NGS) applications. Kapa Biosystems will custom manufacture versions of its KAPA Stranded RNA-Seq Kits for Roche NimbleGen to distribute with its recently launched SeqCap RNA Target Enrichment […]

BILLERICA, Mass. — — RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the formation of the RainDance HemOnc Consortium, composed of a select group of hematologic clinical research experts drawn from prominent comprehensive cancer centers in the U.S. and Europe. Members of the consortium will present first […]

WILMINGTON, Mass. -– Kapa Biosystems, Inc. today announced the expansion of its commercial operations in Europe with the addition of a direct sales and support channel for the United Kingdom. To help ensure the highest level of customer service and satisfaction, the company will be working closely with Anachem Ltd. to facilitate a seamless transition […]

CANOGA PARK, Calif. — One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of research and in vitro diagnostic products for the HLA transplant community, today launched its RUO NXType™ Kit, a research use only (RUO) solution for human leukocyte antigen (HLA) typing by next-generation sequencing (NGS). The NXType sequencing kits feature long-range […]

IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property based businesses, is pleased to note that portfolio company Genomics Ltd (“Genomics” or “the Company”), a spin-out from the University of Oxford that has developed an analytical platform for genomic sequence data analysis, has completed a £10.3 million fundraising. The […]

Bioo Scientific was awarded a National Science Foundation Phase II grant for $750,000 to continue development efforts to improve the accuracy of small RNA expression analysis. The value for developing a method to measure the true profile of microRNAs in a sample would be immense for the research community studying transcriptional regulation, and would open […]

AUSTIN, TX –– Lab7 Systems, Inc., the developer of the Enterprise Sequencing Platform for the management of next-generation genome sequencing (NGS) data and workflows, has announced BioBuilds 2014.11, a major expansion of the BioBuilds library, and the launch ofBioBuilds.org, the home of the BioBuilds project. BioBuilds is a curated and versioned reference collection of Open […]

Marcy l’Etoile, France – San Diego, California, United States –– bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina, a world leader in genomics, announced they have signed an exclusive agreement to launch a next-generation sequencing (NGS) epidemiology solution for service labs. The two companies will jointly develop applications for microbiology […]

Swift Biosciences, Inc. has announced the launch of an early access program for Accel-NGS™ Amplicon Panels for use with Illumina Next Generation Sequencing (NGS) systems. The assays are compatible with FFPE and circulating cell free DNA from 10 ng of genomic DNA. The underlying technology enables hundreds of primer pairs to be amplified in a […]